International Patent: LIPID-BASED FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS FOR ENGINEERING IMMUNE CELLS

GENEVA, July 9 -- STYLUS MEDICINE, INC. filed a patent application (US2026/010059) for “LIPID-BASED FORMULATIONS FOR DELIVERY OF NUCLEIC ACIDS FOR ENGINEERING IMMUNE CELLS”. With publication no. WO/2026/148213, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C12N 15/85

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....